Alterations of insulin secretion from mouse islets treated with sulphonylureas: perturbations of Ca2+ regulation prevail over changes in insulin content
- 1 August 1999
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 127 (8), 1883-1891
- https://doi.org/10.1038/sj.bjp.0702731
Abstract
1. To determine how pretreatment with sulphonylureas alters the beta cell function, mouse islets were cultured (18 - 20 h) without (controls) or with (test) 0.01 microM glibenclamide. Acute responses to glucose were then determined in the absence of glibenclamide. 2. Test islets were insensitive to drugs (sulphonylureas and diazoxide) acting on K+-ATP channels, and their [Ca2+]i was already elevated in the absence of stimulation. 3. Insulin secretion was increased in the absence of glucose, and mainly stimulated between 0 - 10 instead of 7 - 20 mM glucose in controls. The maximum response was halved, but this difference disappeared after correction for the 45% decrease in the islet insulin content. 4. The first phase of glucose-induced insulin secretion was abrogated because of a paradoxical decrease of the high basal [Ca2+]i in beta cells. The second phase was preserved but occurred with little rise of [Ca2+]i. These abnormalities did not result from alterations of glucose metabolism (NADPH fluorescence). 5. In islets cultured with 50 microM tolbutamide, glucose induced biphasic increases in [Ca2+]i and insulin secretion. The decrease in the secretory response was matched by the decrease in insulin content (45%) except at maximal glucose concentrations. Islets pretreated with tolbutamide, however, behaved like those cultured with glibenclamide if tolbutamide was also present during the acute functional tests. 6. In conclusion, treatment with a low glibenclamide concentration causes long-lasting blockade of K+-ATP channels and rise of [Ca2+]i in beta cells. Glucose-induced insulin secretion occurs at lower concentrations, is delayed and is largely mediated by a modulation of Ca2+ action on exocytosis. It is suggested that glucose regulation of insulin secretion mainly depends on a K+-ATP channel-independent pathway during in vivo sulphonylurea treatment.Keywords
This publication has 53 references indexed in Scilit:
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- A Minimum of Fuel Is Necessary for Tolbutamide to Mimic the Effects of Glucose on Electrical Activity in Pancreatic -CellsEndocrinology, 1998
- Parallel reduction of pancreas insulin content and insulin secretion in 48-h tolbutamide-infused normoglycemic ratsDiabetes, 1997
- Comparison of Pharmacokinetics and Pharmacodynamics of Short- and Long-Term Glyburide Therapy in NIDDMDiabetes Care, 1994
- Secondary failure of oral hypoglycaemic agents: Frequency, possible causes, and managementDiabetes/Metabolism Research and Reviews, 1994
- Glyburide and tolbutamide induce desensitization of insulin release in rat pancreatic islets by different mechanismsEndocrinology, 1992
- Potassium selective ion channels in insulin-secreting cells: physiology, pharmacology and their role in stimulus-secretion couplingBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1991
- The cytoplasmic Ca2+ response to glucose as an indicator of impairment of the pancreatic β‐cell functionEuropean Journal of Clinical Investigation, 1990
- Effects of tolbutamide pretreatment on the rate of conversion of newly synthesized proinsulin to insulin and the compartmental characteristics of insulin storage in isolated rat isletsDiabetes, 1986
- Long-term effects of glibenclamide on the insulin production, oxidative metabolism and quantitative ultrastructure of mouse pancreatic islets maintained in tissue culture at different glucose concentrationsActa Diabetologica, 1981